ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
26 hedge funds and large institutions have $3.67M invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$190K | |
| 2 | +$38.1K | |
| 3 | +$32.4K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$13.7K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.09K |
Top Sellers
| 1 | -$22.2K | |
| 2 | -$6.87K | |
| 3 | -$1.21K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$1.04K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$853 |